A famous man, John Quincy Adams, once said, “If your actions inspire others to dream more, learn more, do more and become more, you are a leader”. Mr Adams was the sixth president of the United States of America—and the first to give an interview to a female journalist, Anne Royall, which was quite progressive for his time.
Health Action International Presents “Minutes to Die” at the Dutch Global Health Film Festival
by BIRTE BOGATZ, Communications Advisor
We open the curtain on part three of our “Staff Spotlight” blog series, taking you backstage at Health Action International.
Behind every report, every consultation response, policy brief or methodology there’s a person—most of the time even more than one, because Policy Advisors, Project Managers, Communications & Co. here at HAI work hand in hand.
by MOLLY LEPESKA
An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes & Endocrinology. Co-authored by ACCISS Study leaders, David Beran, Marg Ewen and Richard Laing, the Review describes why insulin is still unattainable for approximately half of all people who need it.
by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator
The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities, is immense. An estimated 100 million people with diabetes need it. This includes all with type 1 diabetes, plus 20 to 30 per cent of people with type 2 diabetes.
by MARGARET EWEN
Many countries, no matter their geographic region or level of economic development, have tremendous opportunity to improve medicines prices, availability and affordability for their citizens. To aid in this endeavour, various medicines policies and interventions exist. It can be difficult, however, for countries to determine which policies and interventions to implement;
The EU will not be changing its aggressive approach to IP protection in bilateral trade agreements, according to the updates that representatives from the European Commission gave at a State of Play meeting with civil society on June 27, 2011. Despite years of opposition and outrage by the global public health community, the EU continues to pursue high IP standards in trade deals with developing countries.
The livelihoods of millions of patients are at risk under the terms of a new trade deal being negotiated by the EU and India which has been hijacked by big business, highlights a new joint report from Corporate Europe Observatory and India FDI.